Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

U.S. Customs and Border Protection officers in Cincinnati recently seized more shipments containing unapproved medications.

Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

Customs and Border Protection officers will continue to work with the trade industry and our consumer safety partners to ...